Results for
"[search-keyword]"
Sponsor content
16 result(s) found, displaying 11 to 16
-
Prescription medicine decision summaryTGA decision: Pemazyre (pemigatinib) is approved to treat cancer
-
Prescription medicine registrationActive ingredients: pemigatinib.
-
Designation or determinationProvisional determination
-
Designation or determinationOrphan drug
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ILUVIEN fluocinolone acetonide 190 mcg intravitreal implant in applicator.
-
Prescription medicine registrationActive ingredients: fluocinolone acetonide.